Allow Cookies!
By using our website, you agree to the use of cookies
Around the world, I am seeing efforts were being made to ‘quick-fixing’ programmes aimed to developing vaccines and therapeutics against COVID-19 but as per my own view and suggestion , standard protocols needs to be made for assuring that specific and certain essentials will result in safeguarding health , Before allowing use of any COVID-19 vaccine in humans, or regulators should evaluated safety with developed ranges of virus strains more than one animal model and The same would also be demand for strong preclinical evidence that the experimental vaccines prevent infection, even though that will probably mean waiting for weeks or even though months for reaching to an available store.
Coronavirus: hospitals must learn from past pandemics
More than 100 COVID-19 treatments were listed in China’s public clinical-trials registry. Most of these involve drug that has already been approved for another diseases. That means they don’t need to act specifically against human coronaviruses, even though that would usually be required by Chinese regulators. What is more, trials needs to done is to gain approval of such treatment of other diseases often not to considered combinations with other drugs. The potential for synergistic toxicity needs to assessed before such ‘old’ drugs entered into COVID-19 treatment regimes.
Testing vaccines and medicines without taking any more time needs to understand the health safety risks during unjustified setbacks of current pandemic. The public’s willingness only to back themselves with quarantines for public-health safety measures to avoid fast spread of virus and follows only government’s health public related advisory and therefore rush the same with risky vaccines and therapies will betray that trust due to lack of proper scientific evidence and discourage them to work and develop better assessments. Despite the genuine requirement needs for urgency, the old phrase says: measure twice, cut once.
Oxford University professor Sunetra Gupta, the epidemiologist, has been tagged for her argument against lockdowns imposed as countermeasure for Covid-19 pandemic. In conversation with Hindustan Times, professor Gupta explained that why most people don’t need Covid-19 vaccines and lockdowns were not being long-term solution regarding containment for the reason of coronavirus.
How does it work
Once taken, the drug makes use of neutralising antibodies, that are produced by body's immune system to restrict themselves from virus infecting the cells. The team managed only for isolated these from blood of 60 more recovered patients, AFP stated.
The team's of expertise lies in single-cell genomics , realised that the approach helped them to find the neutralising antibody nutrients .
When can we expect it
The drug is expected to reached the market later this year and will help to combat potential winter outbreak of virus spread which is gripping whole world.
86540
103860
630
114
59824